Recopharma is a biotechnology company focused on the research and development of ophthalmic products based on protein-carbohydrate interactions. The Company has developed a unique technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The Company’s products will provide a natural alternative to the currently available ocular lubricants and tear substitutes and will be used as a prophylactic against and treatment for viral conjunctivitis. Recopharma’s technology has many other potential future applications, including in vaccine adjuvants and transplantations.